These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ; J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411 [TBL] [Abstract][Full Text] [Related]
3. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura. Rubinstein PG; Chen YH Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323 [No Abstract] [Full Text] [Related]
4. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura. Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245 [TBL] [Abstract][Full Text] [Related]
5. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP). Rewald MD; Francischetti MM Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747 [TBL] [Abstract][Full Text] [Related]
6. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649 [TBL] [Abstract][Full Text] [Related]
7. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura. Chun NS; Savani B; Seder RH; Taplin ME Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210 [TBL] [Abstract][Full Text] [Related]
8. A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP). Tarantino MD; Bussel JB; Cines DB; McCrae KR; Gernsheimer T; Liebman HA; Wong WY; Kulkarni R; Grabowski E; McMillan R Blood; 2007 Jun; 109(12):5527; author reply 5528. PubMed ID: 17554071 [No Abstract] [Full Text] [Related]
9. Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura. Golla S; Horkan C; Dogaru G; Teske TE; Christopher K Acta Haematol; 2008; 120(2):100-3. PubMed ID: 18957844 [TBL] [Abstract][Full Text] [Related]
10. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Freiberg A; Mauger D Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746 [TBL] [Abstract][Full Text] [Related]
11. Severe hemolysis following administration of Rh(o)(D) immune globulin in an ITP patient associated with anti-C. Schwartz J; Spitalnik S; Grima KM Blood; 2006 Mar; 107(6):2585. PubMed ID: 16517982 [No Abstract] [Full Text] [Related]
12. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura. Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011 [TBL] [Abstract][Full Text] [Related]
16. Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model. Gaines AR; Lee-Stroka H; Byrne K; Scott DE; Uhl L; Lazarus E; Stroncek DF Transfusion; 2009 Jun; 49(6):1050-8. PubMed ID: 19220820 [TBL] [Abstract][Full Text] [Related]
17. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura. Ramadan KM; El-Agnaf M Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495 [TBL] [Abstract][Full Text] [Related]
19. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura. Gaines AR Blood; 2005 Sep; 106(5):1532-7. PubMed ID: 15878975 [TBL] [Abstract][Full Text] [Related]
20. What is the mechanism for acute hemolysis occurring in some patients after intravenous anti-D therapy for immune thrombocytopenic purpura? Garratty G Transfusion; 2009 Jun; 49(6):1026-31. PubMed ID: 19638151 [No Abstract] [Full Text] [Related] [Next] [New Search]